| 2022-05-03 | Sale | Heron Therapeutics, Inc. HRTX | EVP, Drug Development | 1,504 0.0015% | $4.76 | $7,154 | -38.95% | |
| 2021-05-03 | Sale | Heron Therapeutics, Inc. HRTX | EVP, Drug Development | 3,058 0.0032% | $17.66 | $54,017 | -39.34% | |
| 2020-12-22 | Sale | Heron Therapeutics, Inc. HRTX | EVP, Drug Development | 20,000 0.0176% | $16.50 | $330,000 | -32.95% | |
| 2020-05-01 | Sale | Heron Therapeutics, Inc. HRTX | Executive VP, Drug Development | 2,316 0.0013% | $6.98 | $16,176 | +25.16% | |
| 2019-11-29 | Sale | Heron Therapeutics, Inc. HRTX | Executive VP, Drug Development | 48,000 0.0274% | $13.00 | $624,000 | -35.68% | |
| 2019-05-01 | Sale | Heron Therapeutics, Inc. HRTX | Executive VP, Drug Development | 2,218 0.003% | $18.86 | $41,836 | +3.61% | |
| 2018-11-02 | Sale | Heron Therapeutics, Inc. HRTX | Executive VP, Drug Development | 988 0.0014% | $30.62 | $30,250 | -30.06% | |
| 2018-10-01 | Sale | Heron Therapeutics, Inc. HRTX | Executive VP, Drug Development | 12,000 0.0119% | $22.54 | $270,433 | -23.68% | |
| 2018-07-02 | Sale | Heron Therapeutics, Inc. HRTX | Executive VP, Drug Development | 12,000 0.015% | $37.53 | $450,357 | -30.39% | |
| 2018-03-19 | Sale | Heron Therapeutics, Inc. HRTX | Executive VP, Drug Development | 36,000 0.0438% | $21.50 | $774,000 | +9.71% | |
| 2018-01-10 | Sale | Heron Therapeutics, Inc. HRTX | Executive VP, Drug Development | 15,168 0.019% | $16.50 | $250,272 | +47.17% | |
| 2017-04-24 | Sale | Heron Therapeutics, Inc. HRTX | Executive VP, Drug Development | 43,084 0.0803% | $15.33 | $660,525 | +6.54% | |
| 2015-06-02 | Sale | Heron Therapeutics, Inc. HRTX | director | 21,000 0.0688% | $23.58 | $495,180 | +12.42% | |
| 2015-06-01 | Sale | Heron Therapeutics, Inc. HRTX | director | 5,416 0.0108% | $15.11 | $81,836 | +6.98% |